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Aims Ca2+ waves are thought to be important in the aetiology of ventricular tachyarrhythmias. There have been conflicting
results regarding whether flecainide reduces Ca2+ waves in isolated cardiomyocytes. We sought to confirm whether
flecainide inhibits waves in the intact cardiomyocyte and to elucidate the mechanism.
Methods
and results
We imaged spontaneous sarcoplasmic reticulum (SR)Ca2+ release events in healthy adult rat cardiomyocytes. Variation
in stimulation frequencywas used to produceCa2+ sparks orwaves. Spark frequency, wave frequency, andwave velocity
were reduced by flecainide in the absence of a reduction of SR Ca2+ content. Inhibition of INa via alternative pharma-
cological agents (tetrodotoxin, propafenone, or lidocaine) produced similar changes. To assess the contribution of INa to
spark and wave production, voltage clamping was used to activate contraction from holding potentials of 280 or
240 mV. This confirmed that reducing Na+ influx during myocyte stimulation is sufficient to reduce waves and that fle-
cainide only causes Ca2+ wave reduction when INa is active. It was found that Na
+/Ca2+-exchanger (NCX)-mediated
Ca2+ efflux was significantly enhanced by flecainide and that the effects of flecainide on wave frequency could be
reversed by reducing [Na+]o, suggesting an important downstream role for NCX function.
Conclusion Flecainide reduces spark and wave frequency in the intact rat cardiomyocyte at therapeutically relevant concentrations
but themechanism involves INa reduction rather than direct ryanodine receptor (RyR2) inhibition. Reduced INa results in
increased Ca2+ efflux via NCX across the sarcolemma, reducing Ca2+ concentration in the vicinity of the RyR2.
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1. Introduction
Ca2+ waves are thought to be important in the aetiology of a number
of different forms of ventricular tachyarrhythmia, particularly in heart
failure (HF) and catecholaminergic polymorphic ventricular tachycar-
dia (CPVT).1 The mechanisms for these arrhythmias are thought to be
associated with elevated levels of spontaneous sarcoplasmic reticulum
(SR) Ca2+ release for a given SR load.1,2 In other words, the threshold
SR Ca2+ content for store-overload-induced Ca2+ release is reduced
in both CPVT and in HF,2–4 leading to Ca2+ spark and wave gener-
ation. In CPVT, this is related to mutations of the cardiac ryanodine
receptor (RyR2) or absence of calsequestrin, whereas in HF this
may relate to post-translational modification of the RyR2, such as
hyperphosphorylation.2,5
There has been recent interest in pharmacological agents which
target potentially arrhythmogenic Ca2+ waves. Flecainide, a drug
that has been used for many years clinically for its sodium current
(INa)-reducing properties, has shown efficacy in the treatment of
CPVT patients.6,7 However, the mechanism of action producing this
clinical effect is debated. In a mouse model of CPVT, Knollmann
and colleagues7–9 have shown that flecainide reduces Ca2+ wave fre-
quency in both intact and permeabilized myocytes and have provided
evidence that this is related to a direct action on the RyR2 via an
open-state block of the channel. In contrast, similar experiments in
both intact and permeabilized myocytes have been repeated by Liu
et al.10 (although in a different mouse model of CPVT), and no
effect on Ca2+ wave frequency was found despite similar experimen-
tal conditions. The conclusion of Liu et al. was that the reduction in INa
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caused by flecainide affected the threshold potential, which decreased
the number of spontaneous action potentials triggered by delayed
after-depolarizations (DADs) associated with Ca2+ waves.
Our aim in this study was to assess whether flecainide had an effect
on Ca2+ sparks and waves and to further investigate the mechanism.
We observed SR Ca2+ release events in intact rat ventricular cardio-
myocytes from healthy rats. We show via a variety of pharmacological
and electrophysiological interventions that a reduction in INa during
cellular contraction can reduce the frequency of Ca2+ sparks and
waves in the diastolic period. We also show that, in the case of flecai-
nide, the INa blocking effects are more relevant to wave reduction
under our experimental conditions than RyR2 stabilization. Finally,
we explore the mechanism of this wave reduction. We conclude
that the most likely explanation for the reduction in the presence
of INa blockade is that it prevents an increase in [Na
+]i resulting in
more effective Na+/Ca2+-exchanger (NCX)-mediated efflux of Ca2+.
2. Methods
2.1 Ventricular myocyte isolation and Ca21
imaging
Extended methods are available in Supplementary material online. All
animal surgical procedures and peri-operative management were carried
out in accordance with the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH Publica-
tion, 8th Edition, 2011) under assurance number A5634-01. Imperial
College Ethical Review Committee authorized the project licence. Rats
were sacrificed by cervical dislocation following exposure to 5% isoflurane
until righting reflex was lost. Cardiac myocytes were enzymatically iso-
lated from the left ventricle of healthy adult male Sprague Dawley rats
by the Langendorff perfusion technique.11 Intact isolated myocytes were
loaded with the Ca2+-sensitive fluorescent dyes fluo-4AM or fura-2AM
prior to imaging.
2.2 Intracellular Ca21 measurements
Experiments were performed with cells undergoing superfusion at 378C.
Transients were assessed during steady-state external field stimulation at
0.5 Hz. Sparks were recorded following cessation of 0.5 Hz contraction
during the last 10 s of a 25 s period of quiescence. Diaz et al.12 have pre-
viously shown that [Na+]i rises when quiescent cardiomyocytes are sti-
mulated and that this, together with higher SR Ca2+ content, was
correlated with increased wave frequency. Similarly, in our experiments,
a higher stimulation frequency was associated with an increased wave fre-
quency in a subsequent quiescent period, presumably for similar reasons
(see Supplementary material online, Figure S1A). This preliminary series of
experiments established that 30 s of 5 Hz stimulation (after 2 min of stable
contraction at 0.5 Hz) would consistently produce Ca2+ waves in normal
tyrode (NT) in the quiescent interval.
2.3 Voltage clamp technique
Cells were voltage-clamped using an amphotericin-perforated patch tech-
nique. The switch clamp technique [with an Axoclamp 2B amplifier (Axon
Instruments)] was used to overcome any changes in access resistance that
may have occurred over the course of an experiment. Myocytes were
clamped at 280 or 240 mV and depolarized to 0 mV for 100 ms to
cause contraction with and without INa activation, respectively. A 5 Hz
stimulation train was followed by a quiescent period during which the
membrane potential was held at 280 mV for 30 s, and wave frequency
was assessed as before.
2.4 Data-pairing and statistical analysis
Where possible, data were obtained in a paired fashion and drugs applied
or washed off in the form of a cross-over protocol alternating from cell to
cell (Figure 1A). For example, the first cell had the drug applied following a
control period, whereas the next cell had drug applied first with subse-
quent wash-off.
As a result, paired t-tests were used for significance testing unless
stated. Depending on the data, Student’s t-tests, log-rank, and repeated-
measures analysis of variance (ANOVA) were also used to assess
effects. Results were considered statistically significant if the P-value was
,0.05. Unless otherwise indicated, results are expressed as mean+
standard error of the mean.
3. Results
3.1 Flecainide has no effect on the Ca21
transient or SR Ca21 load
We first assessed the effect of 5 mM flecainide on the amplitude of
Ca2+ transients evoked by external field stimulation at 0.5 Hz. Stimula-
tion continued at the same rate during the 5 min wash-on or wash-off
periods. Ca2+ transient amplitude did not change significantly in the
presence of flecainide (Figure 1B). Similarly, transient morphology was
unchanged (see Supplementary material online, Figure S1B and C). SR
load was measured using a 20 mM caffeine spritz in 0Na+/0Ca2+ solu-
tion following field stimulation at 5 Hz to mimic conditions used to
assess waves (Figure 1C) and was unchanged by flecainide.
3.2 Flecainide reduces Ca21 spark and wave
frequency and Ca21 wave velocity
Spark frequency was significantly reduced with exposure to flecainide
compared with NT alone from 3.25+0.36 to 2.38+0.34 sp/
100 mm/s (Figure 1D and E). Spark morphology was unchanged (see
Supplementary material online, Figure S2A–D).
We predicted that the reduction in spontaneous Ca2+ sparks from the
SR in the presence of flecainide would result in a reduction in wave fre-
quency. In order to test this hypothesis, 5 Hz stimulation was used to
producewaves. Therewas a reduction inCa2+wave frequency in the pres-
enceofflecainide (Figure2A) from0.23+0.04 to0.10+0.02waves/s (P¼
0.001). Since it has previously been suggested that a prolonged period of
flecainide loading is required to produce SR Ca2+ release reduction,9 we
tested whether prolonged exposure would have any additional effect.
Thirty minutes of exposure produced no further wave reduction com-
pared to 5 mins (see Supplementary material online, Figure S3A).
The time from the last transient to the first wave, defined as the
‘wave-free survival period’ for each cell, and represented in Kaplan–
Meier survival curve format in Figure 2B, was also significantly
increased in the presence of flecainide. In addition, wave velocity
was reduced (Figure 2C) from 146.4+ 4.7 to 130+5.8 mm/s (P ¼
0.04 by Student’s t-test), suggesting that wave propagation is also
altered by flecainide. Confocal line-scanning reveals both the reduc-
tion in Ca2+ waves and how this is related to a reduction in spark fre-
quency (Figure 2D). Wave amplitude did not change significantly in the
presence of flecainide (see Supplementary material online, Figure S3B).
3.3 Specific INa blockade decreases spark
and wave frequency
There are two broad mechanisms which may be responsible for the
reduction in Ca2+ waves in the presence of flecainide. First, by
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blocking Ca2+ release from the RyR2, for which there is conflicting
evidence in CPVT myocytes,9,10 and second by inhibiting Na+ influx
with subsequent downstream effects. We aimed to assess the latter
possibility—namely, whether SR Ca2+ release can be altered by redu-
cing Na+ influx.
We therefore assessed the effect of specific pharmacological inhib-
ition of INa using 5 mM tetrodotoxin (TTX), a dose which was
selected since it provides 25% INa blockade in cardiomyocytes,
13
which is similar to that provided by 5 mM flecainide,14 while still allow-
ing Ca2+ transients to occur with external field stimulation. Spark fre-
quency was reduced (Figure 3A) from 3.76+ 0.48 to 2.24+0.52 sp/
mm/s in the presence of TTX (P ¼ 0.009). TTX also significantly
reduced wave frequency (Figure 3B) and caused a reduction in wave
velocity (Figure 3C) without changing wave amplitude (see Supplemen-
tary material online, Figure S3B). Similar to results with flecainide,
application of TTX at this concentration resulted in no significant al-
teration of SR load (Figure 3D). To assess whether this was a general
property of other INa blockers, further experiments to assess wave
frequency under similar degrees of INa blockade by 5 mM propafe-
none15 and 200 mM lidocaine16 were carried out. Both agents
reduced waves in a similar manner to flecainide and TTX (Figure 3E
and F ). Together, these results strongly suggest that INa is involved
in wave formation.
3.4 How does INa reduction decrease Ca
21
waves?
Two main possibilities could explain the involvement of INa in wave
formation. The first is that Na+ entry via Nav1.5 channels alters the
sub-sarcolemmal ‘fuzzy’ space [Na+] which subsequently modifies
wave propagation via a number of possible downstream mechanisms
Figure 1 Experimental protocol and effects of flecainide on Ca2+ transients and Ca2+ sparks. (A) Experimental flowchart to explain cross-over
protocol used in experiments. Fifty per cent of cells had NT applied first with drug wash-on, whereas 50% had drug applied first and subsequently
washed-off. (B) Stimulated Ca2+ transients were assessed using the ratiometric dye fura-2 calibrated to give [Ca2+]i. Transient amplitude was not
changed in the presence of 5 mM flecainide (n ¼ 30 cells, P ¼ 0.19). (C) 20 mM caffeine in 0Na+/0Ca2+ solution was used to assess SR Ca2+ load
following a 5 Hz contraction train. The amplitude was unchanged in the presence of 5 mM flecainide (n ¼ 13 cells in each group, P ¼ 0.96 by Student’s
t-test). (D) Spark frequency was reduced following flecainide application (n ¼ 24 cells, P ¼ 0.002). (E) Representative line-scans showing a reduction in
spark frequency with flecainide. The same cell is shown before and after flecainide application.
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(Mechanism A, Figure 4A). The second is that Nav1.5 channel activa-
tion is involved in the process of wave initiation and propagation
more directly at the wave front (Mechanism B, Figure 4B).
If Mechanism A is accurate, then given its dependence on Na+
influx via Nav1.5, wave frequency should be reduced by an interven-
tion which reduces Na+ influx during the contraction train but leaves
Nav1.5 channels available during the quiescent period following the
contraction train. Such a scenario was created using a voltage clamp
technique to inactivate INa during the stimulation train. Cells were sti-
mulated by a 5 Hz train of clamp pulses (100 ms in duration) from
280 to 0 mV repeatedly for 1 min and waves assessed during a sub-
sequent 30 s quiescent period when the cells were held at 280 mV.
The same cell was re-stimulated by another train of pulses from 240
to 0 mV, thereby removing Na+ influx due to INa inactivation. The
final holding potential during the quiescent period was 280 mV as
before to ensure availability of Nav1.5 channels (Figure 5A). There
was a significant reduction in wave frequency from 0.30+0.04 to
0.16+0.03 waves/s following inactivation of INa by voltage clamp
(Figure 5B), suggesting greater importance of Mechanism A.
To confirm these findings and assess whether Mechanism B might
also be playing a role, we designed an experiment which would allow
normal Na+ influx during the contraction train but would profoundly
reduce availability of Nav1.5 channels during the quiescent phase. A
stimulation train was induced by external field stimulation for 30 s
at 5 Hz and waves were assessed as before in the control condition
(NT + vehicle). The same cell was then exposed to the same proto-
col but high-dose TTX (50 mM TTX, which blocks .95% of INa
13 ) was
superfused over cells rapidly after 30 s stimulation in NT to stop the
Figure 2 Effects of 5 mM flecainide on Ca2+ waves. (A) Flecainide was washed on or off via cross-over protocol for 5 min. In the presence of fle-
cainide, wave frequency was significantly reduced (P ¼ 0.001, n ¼ 20 cells). (B) Latency period from the last transient to the first wave is shown in the
Kaplan–Meier survival format (i.e. wave-free survival). Cells in the presence of flecainide have an increased wave-free survival period (P ¼ 0.002 by
log-rank test, n ¼ 20 cells). (C) Wave velocity is reduced in the presence of flecainide (P ¼ 0.04 by Student’s t-test, NT: n ¼ 81 waves; flec: n ¼ 36
waves from 20 cells). (D) Representative line-scans from a cell assessed for waves pre- and post-flecainide application. The end of the 30 s period of
5 Hz stimulation evoking Ca2+ transients can be seen at the top of the scans with subsequent quiescent phase during which waves are observed. Areas
of increased spark activity prior to waves are highlighted with white arrows and are more prominent in the absence of flecainide. Inset: line-scans
converted into F/F0 plots—reduction of wave frequency and increased latency is apparent.
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contraction train. This caused contractions and stimulated Ca2+
transients to cease almost immediately despite continuation of field
stimulation at the same voltage (see Supplementary material online,
Figure S5). This provided evidence of Nav1.5 blockade during the qui-
escent period while ensuring the SR loading protocol was identical.
Results of these experiments showed that acute, profound Nav1.5
blockade did not alter Ca2+ wave frequency or velocity (Figure 5C
and D), suggesting that Mechanism B either does not occur or is of
relatively minor importance compared with Mechanism A.
3.5 Mechanism of wave reduction with
flecainide
Having shown that INa reduction during the contraction train can
reduce the frequency and velocity of Ca2+ waves, we wished to
assess whether this effect also played a role in the effects we had
observed with flecainide. We first assessed whether, in the absence
of INa, flecainide would still reduce wave frequency—potentially
through an additional effect on the RyR2. In order to test this possi-
bility, we performed voltage clamp experiments. With a stimulation
train of voltage clamp steps from 280 to 0 mV, as expected, there
was a significant reduction in Ca2+ waves (Figure 5E) in the presence
of flecainide. However, when the stimulation train was induced by
voltage steps from 240 to 0 mV (and so INa was inactivated), there
was no significant reduction in Ca2+ wave frequency (Figure 5F) in
the presence of flecainide. This provided evidence that reduced
Na+ influx was crucial in flecainide’s mechanism of wave reduction.
To investigate how the changes in Na+ influx into the cytosol
altered wave frequency, we identified two possibilities that we felt
were most likely to be the cause of the change. First, a reduction in
Figure 3 Effects of INa inhibition by tetrodotoxin (TTX), propafenone and lidocaine on SR Ca
2+ release events. (A) 5 mM TTX applied via similar
cross-over protocol to flecainide experiments induced a similar reduction in Ca2+ spark frequency (P ¼ 0.009, n ¼ 14 cells). (B) 5 mM TTX reduced
wave frequency (P ¼ 0.0002, n ¼ 10 cells). (C) Wave velocity is significantly reduced in the presence of TTX (P ¼ 0.012 by Student’s t-test, NT:
n ¼ 84 waves; TTX: n ¼ 34 waves from 10 cells). (D) Similar to flecainide experiments, no significant change in SR load was seen in the presence
of 5 mM TTX (P ¼ 0.97 by Student’s t-test, n ¼ 20 cells from three isolations). (E) 5 mM propafenone reduced Ca2+ wave frequency in a similar
manner (P ¼ 0.0007, n ¼ 10 cells), as did (F) 200 mM lidocaine (P ¼ 0.0012, n ¼ 10 cells).
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Figure 4 Possible hypotheses to explain how INa can contribute to wave initiation and propagation. (A) Entry of Na
+ ions occurs via INa and an
alteration of wave properties may result from changes in [Na+]i, particularly in the sub-sarcolemmal space. In this proposed mechanism (1) increased
fuzzy space [Na+] provides a milieu that enhances the probability of (2) Ca2+ sparks leading to (3) the activation and firing of an adjacent RyR cluster
to result in (4) wave initiation and propagation throughout the cell. (B) Alternatively Nav1.5 channels may be involved in wave propagation per se in the
intact cardiomyocyte. Such involvement could comprise (1) spontaneous SR Ca2+ release in the form of a spark resulting in (2) local Ca2+ efflux by
NCX causing (3) local depolarization of the sarcolemma, which (4) subsequently results in local activation of INa and ICa assisting the rise in local (‘fuzzy
space’) [Ca2+]i that can lead to (5) adjacent RyR clusters firing and (6) wave propagation.
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Figure 5 Elucidation of Mechanism A as most likely cause for reduction in Ca2+ waves due to INa blockade. (A) Voltage clamp stimulation trains
used to assess wave frequency with and without INa activity. Stimulation was induced by stepping from 280 to 0 mv (INa active) or 240 to 0 mV (INa
inactive). Pulse duration was 100 ms and pulses were applied at 5 Hz. Waves were assessed in a subsequent 30 s interval during which membrane
potential was held at 280 mV. (B) With INa inactive during the stimulation train (but available during the quiescent phase of the experiment),
wave frequency was reduced (P ¼ 0.002, n ¼ 7 cells). (C) High-dose (50 mM) TTX was rapidly applied to cells to terminate stimulation following
a period of external field stimulation at 5 Hz and compared with the control arm in which stimulation was terminated in the usual fashion at 30 s
(see Supplementary material online, Figure S4 for further explanation). This produced the opposite situation to the previous experiment with INa
active during the stimulation train but Nav1.5 channels unavailable for stimulation during the quiescent phase. This produced no change in wave fre-
quency (P ¼ 0.99, n ¼ 17 cells). (D) Similarly, there was no change in wave velocity (P ¼ 0.66 by Student’s t-test. Control: n ¼ 88 waves; 50 mM TTX:
n ¼ 89 waves from 17 cells). (E) Voltage clamp experiments showing effects of flecainide on wave frequency with INa active vs. inactive. With INa
active, flecainide reduces wave frequency (P ¼ 0.001, n ¼ 7 cells). (F ) However, with INa inactive, no reduction in wave frequency was observed
(P ¼ 0.36, n ¼ 7 cells).
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Ca2+/calmodulin-dependent protein kinase II (CamKII) activity as a
result of reduced [Na+]i
17 or [Ca2+]i, and second as a result of
enhanced Ca2+ efflux across the sarcolemma via NCX because of
an enhanced [Na+]o:[Na
+]i gradient.
In order to investigate the former possibility, we used 1 mM KN-93 to
inhibit CamKII prior to the addition of flecainide. In the presence of either
KN-93 (Figure 6A) or KN-92 (see Supplementary material online, Figure
S5A), flecainide remained able to reduce Ca2+ wave frequency.
We subsequently assessed NCX function by observing the rate
constant of Ca2+ efflux following a caffeine transient in NT
under the same conditions as waves were assessed (see Supple-
mentary material online). There was a significant increase in Ca2+
efflux via NCX following a contraction train in the presence of fle-
cainide (Figure 6B). We subsequently assessed how such efflux
would affect diastolic [Ca2+]i in the period following the last field-
stimulated contraction and the first Ca2+ wave, using the ratio-
metric dye fura-2. We found that there was a significant reduction
in diastolic Ca2+ by 12% (P ¼ 0.005, see Supplementary material
online, Figure S5B).
In order to assess whether the opposite effect would occur with
the inhibition of Ca2+ efflux via NCX, we assessed the effects of
partial NCX inhibition18 with 1 mM NiCl2 following the contraction
train and found an increase in waves (Figure 6C). Flecainide enhances
Ca2+ efflux via a reduction of [Na]i, enhancing the [Na
+]o:[Na
+]i gra-
dient; however, this gradient can also be altered by changing [Na+]o.
We sought to do this in the presence of flecainide to reverse the re-
duction in wave frequency. We found that a reduction of [Na+]o after
the contraction train from 140 to 125 mM was sufficient to reverse
the wave reduction seen with flecainide (Figure 6D and E). In order
to ascertain whether the opposite effects would occur with INa en-
hancement, we assessed whether 0.5 mM veratridine could increase
Ca2+ wave frequency. There was a significant increase in waves in
the presence of veratridine which was reversed by increasing [Na]o
from 115 to 140 mM.
4. Discussion
4.1 Main findings
The main finding of this study is that a reduction of INa can reduce the
frequency of Ca2+ sparks and waves and the velocity of Ca2+ waves.
This holds true whether INa is pharmacologically reduced by a variety
of agents or reduced by voltage clamp techniques. Initially, we wished
to clarify whether this occurred via altering the intracellular ionic
milieu (Mechanism A, Figure 4A) or whether Na+ influx was involved
in the process of wave propagation itself (Mechanism B, Figure 4B). A
series of experiments inactivating INa either during the stimulation
train or the quiescent phase (Figure 5) confirmed that a reduction in
Na+ influx is the most important mechanism involved in reducing
Ca2+ waves rather than implicating a role for Nav1.5 channels at
the Ca2+ wave front. In further support of the importance of
changes of cytosolic ionic milieu is the fact that very different INa
blockers including the neurotoxin TTX, class 1c drugs flecainide
and propafenone, and the class 1b drug lidocaine produce a similar re-
duction in Ca2+ wave frequency when concentrations producing
similar degrees of INa blockade are used.
We used voltage clamp to assess whether a reduction in INa was
crucial for this effect. In the absence of INa, flecainide is not able to
reduce Ca2+ waves, suggesting dominance of this mechanism over
RyR2 blockade under our conditions.
The question of how the alteration in cellular ionic milieu reduces
Ca2+ waves is complex and may be multifactorial. A reduction in
[Na+]i is expected to increase [Ca
2+] efflux across the sarcolemma
via NCX and so there is additional complexity since both [Na+]i
and [Ca2+]i may be altered. We went on to investigate how such
changes contribute to wave reduction.
4.2 Mechanism of wave reduction does not
depend on CaMKII
First, Ca2+/calmodulin complex (CaMKII), a major regulator of SR
Ca2+ leak,19 is affected both by [Ca2+]i and directly by [Na
+]i.
17
We investigated the efficacy of flecainide in Ca2+ wave reduction in
the presence of KN-93, an inhibitor of CaMKII, and its inactive ana-
logue KN-92. Wave reduction still occurred in the presence of
either compound. In addition, the efficacy of wave reduction was un-
changed whether KN-93 or KN-92 was present (35 vs. 37% reduc-
tion, respectively), suggesting that CaMKII inhibition does not have a
major role in wave reduction due to INa inhibition.
4.3 Wave reduction does not result from
reduced SR Ca21 load
Another major possibility was that reduced [Na+]i resulted in
enhanced Ca2+ efflux via NCX. This has the potential to decrease
SR luminal [Ca2+]; however, we found that neither 5 mM flecainide
nor 5 mM TTX had significant effects on SR Ca2+ content. This is con-
sistent with the work of previous investigators using similar doses of
flecainide.9,10 Altered NCX function could reduce waves by mechan-
isms unrelated to SR load, however. For example, let us assume that
almost maximal SR load was produced by our experimental condi-
tions in the rat species, and that a tightly controlled SR luminal
Ca2+ threshold exists beyond which sparks and waves occur. In this
case, if INa blockade enhances Ca
2+ efflux via NCX, then SR load
may reach threshold for spark and wave release less frequently
since the SR Ca2+-ATPase would have more competition for Ca2+
ions in the fuzzy space. Since the threshold per se would not
change in this situation (no RyR2 modification), one may not
observe lower SR load but simply less frequent SR Ca2+ release.
4.4 INa reduction increases Ca
21 efflux via
NCX, which reduces Ca21 waves
We performed experiments to assess the possibility of an
NCX-mediated effect on Ca2+ waves despite the absence of SR
Ca2+ load reduction. We assessed NCX function using the decay
constant of NCX-mediated [Ca2+]i decline in the presence of caffeine
and confirmed that Ca2+ efflux via NCX was increased after a con-
traction train in the presence of flecainide (Figure 6B). This resulted
in a slight reduction in diastolic [Ca2+]i in the quiescent period follow-
ing our contraction train as assessed by fura-2 fluorescence (see Sup-
plementary material online, Figure S5B). In order to confirm the
relevance of this mechanism, we modulated NCX function in other
ways. Direct partial inhibition of NCX18 with 1 mM Ni2+ applied
after the contraction train increased Ca2+ waves (Figure 6C), suggest-
ing that NCX is functioning predominantly in the inward mode under
our experimental conditions. Impairing NCX increases waves by re-
ducing Ca2+ efflux. This helps to clarify how INa blockade might
reduce Ca2+ waves. In the presence of lower [Na+]i, NCX would
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Figure 6 Role of CaMKII and NCX in wave reduction by flecainide. (A) Despite incubation of cells with 1 mM CaMKII inhibitor KN-93, flecainide
was still able to significantly reduce Ca2+ wave frequency. Magnitude of reduction was similar in the presence of inactive analogue KN-92 (see Sup-
plementary material online, Figure S5A), suggesting CaMKII inhibition is not the mechanism of wave reduction with flecainide. (B) NCX function in
terms of Ca2+ efflux efficacy was significantly improved following a 5 Hz contraction train in the presence of flecainide. (C ) Direct partial inhibition
of NCX by 1 mM Ni2+ applied after the contraction train increased Ca2+ wave frequency. (D) Reduction of [Na+]o after the contraction train can
reverse the reduction in wave frequency seen with flecainide. (E) Pooled data from experimental protocol shown in (D) revealing that a reduction in
wave frequency induced by flecainide can be reversed by reducing [Na+]o to 125 mM. (F ) 0.5 mM veratridine can increase Ca
2+ wave frequency via
enhancing INa. This effect was abolished by increasing [Na
+]o from 115 to 140 mM.
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provide more effective Ca2+ efflux at resting membrane potentials.20
On the other hand, a lower [Na+]o would shift the reversal potential
of NCX in the negative direction. As such, if altered NCX function
resulting from reduced [Na+]i was the cause of wave reduction in
the presence of flecainide, we expected that such an effect could
be abrogated by a reduction in [Na+]o. Indeed, we found that redu-
cing [Na+]o from 140 to 125 mM in the period following the contrac-
tion train completely reversed the reduction in Ca2+ waves seen with
flecainide (Figure 6E).
Finally, we provide evidence that an increase in INa can increase
Ca2+ wave frequency, using the Nav1.5 channel activator veratridine
(Figure 6F). The subsequent reduction in wave frequency by increasing
[Na]o shows that increasing Ca
2+ efflux via NCX can reverse
this effect.
Direct blockade of NCX function using a selective NCX blocker
may have been a useful approach to highlight the importance of
[Na+]i on waves. However, most NCX blockers have off-target
effects. Even when these are limited, such as in the case of
SEA-0400, they still produce a reduction of ICa via intracellular accu-
mulation of Ca2+ which causes inhibition of the L-type Ca2+ current
via Ca2+-dependent inactivation.21 Hence, it was felt that direct NCX
blockade with small molecule inhibitors may yield results that could
be more difficult to interpret than modulating NCX function via
alterations in [Na+]o to counteract the changes in [Na
+]o:[Na
+]i gra-
dient caused by INa blockade.
4.5 INa blockers and SR Ca
21 release
Although it is accepted that Na+ influx can, via subsequent efflux by
NCX, cause Ca2+ entry and generation of contractile force,22 and
even that Ca2+ entry via the exchanger can induce Ca2+ sparks,23
NCX has been largely neglected in the investigation of how INa inhi-
bitors can reduce SR Ca2+ release. This is largely because, at high con-
centrations (e.g. 20 mM flecainide), some INa inhibitors have direct
effects on RyR2 in permeabilized cells and lipid bilayer experi-
ments.7–9 It is not possible to compare our experiments directly
with such previous work since ventricular myocytes from mouse
models of CPVT were used. In these studies, contrasting results
were presented, with Knollman and co-workers7,9 reporting a reduc-
tion in wave frequency but increased spark frequency in both intact
Casq2/2 and permeabilized normal rat ventricular myocytes and
Liu et al.10 finding no changes in sparks or waves with flecainide in
either intact or permeabilized ventricular cardiomyocytes from
RyR2R4496C+/2 mice.
This inconsistency led us to investigate further despite the provision
by Knollman and co-workers7,9’ of multiple lines of evidence that
RyR2 inhibition rather than altered Na+ flux is the predominant
mechanism of action in their experiments. In contrast, we find that
without an active Na+ current, no reduction in waves can be
observed with flecainide. In addition, reduction in INa alone, via
various pharmacological agents and voltage clamp techniques, is suffi-
cient to cause a reduction in wave frequency via enhancement of
Ca2+ efflux by NCX. Contributory to the differences between our
work and other studies may be: (i) species difference and lack of
CPVT model in our experiments; (ii) use of supra-therapeutic flecai-
nide concentrations to obtain effects in permeabilized cells and lipid
bilayer experiments by Knollman and co-workers while we used a
therapeutically relevant concentration throughout; and (iii) lack of
paired data in other studies which may reduce the power to detect
differences in wave frequency (perhaps explaining the lack of efficacy
seen with alternative INa blockers such as TTX and lidocaine by
Hwang et al.24).
4.6 Limitations
Rapid application of caffeine is a well-accepted technique to assess SR
load but may be insensitive to subtle changes in store Ca2+ content.
We attempted to minimize inaccuracies by using a ratiometric dye and
applying caffeine in the presence of Na+-free/Ca2+-free solution to
obtain an accurate peak [Ca2+]i.
Our voltage clamp trains from 280 to 0 mV vs. 240 to 0 mV,
designed to eliminate INa, could also alter NCX function during the
contraction train; however, this would promote Ca2+ entry at 240
vs. 280 mV and thus increase Ca2+ waves rather than reduce
them. Hence, this is not responsible for the reduction in wave fre-
quency in the absence of INa.
4.7 Conclusions
Reducing Na+ influx during contraction in the intact cardiomyocyte
reduces spontaneous diastolic SR Ca2+ release both in the form of
Ca2+ sparks and waves. Given that SR load is unchanged, this is the
result of reduced [Ca2+]i in the vicinity of the RyR2 (due to enhanced
efflux via NCX), which reduces the open probability of the channel. In
the intact rat cardiomyocyte, this is the predominant mechanism of
action for the reduction in Ca2+ waves seen with flecainide at thera-
peutic concentrations. Other means of reducing Na+ influx, such as
INa,L reduction, would be expected to reduce SR Ca
2+ leak via
similar mechanisms.
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